Cargando…

Novel Nasal Epithelial Cell Markers of Parkinson’s Disease Identified Using Cells Treated with α-Synuclein Preformed Fibrils

Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, characterized by olfactory dysfunction in the early stages. α-Synuclein pathologies in the olfactory organs are shown to spread to the brain through the nose-brain axis. We first developed a nasal epithelial PD cellular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyojung, Kang, Seok-Jae, Jo, Young Mi, Park, Sanggyu, Yun, Seung Pil, Lee, Yun-Song, Kim, Hee-Tae, Lee, Nae-Eung, Kim, Yong-Sang, Cho, Seok Hyun, Lee, Yunjong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408990/ https://www.ncbi.nlm.nih.gov/pubmed/32640699 http://dx.doi.org/10.3390/jcm9072128

Ejemplares similares

Quantitative analysis of nasal transcripts reveals potential biomarkers for Parkinson’s disease
por: Kim, Hyojung, et al.
Publicado: (2019)

Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson’s Disease Models
por: Verma, Dinesh Kumar, et al.
Publicado: (2021)

Modeling α-Synuclein Propagation with Preformed Fibril Injections
por: Chung, Hyun Kyung, et al.
Publicado: (2019)

Modeling α-Synuclein Propagation with Preformed Fibril Injections
por: Chung, Hyun Kyung, et al.
Publicado: (2020)

Monitoring α-synuclein Aggregation Induced by Preformed α-synuclein Fibrils in an In Vitro Model System
por: Kim, Beom Jin, et al.
Publicado: (2023)

Brain Endothelial P-Glycoprotein Level Is Reduced in Parkinson’s Disease via a Vitamin D Receptor-Dependent Pathway
por: Kim, Hyojung, et al.
Publicado: (2020)

Retina-to-brain spreading of α-synuclein after intravitreal injection of preformed fibrils
por: Pérez-Acuña, Dayana, et al.
Publicado: (2023)

Cell-Based Screen Using Amyloid Mimic β23 Expression Identifies Peucedanocoumarin III as a Novel Inhibitor of α-Synuclein and Huntingtin Aggregates
por: Ham, Sangwoo, et al.
Publicado: (2019)

Alpha-synuclein preformed fibrils: a tool to understand Parkinson’s disease and develop disease modifying therapy
por: Chmielarz, Piotr, et al.
Publicado: (2021)

α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
por: Yun, Seung Pil, et al.
Publicado: (2018)

Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson’s disease model
por: Ham, Sangwoo, et al.
Publicado: (2017)

Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice
por: Earls, Rachael H., et al.
Publicado: (2019)

Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson’s Disease
por: Duffy, Megan F., et al.
Publicado: (2018)

Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
por: Sossi, Vesna, et al.
Publicado: (2022)

A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model
por: Polinski, Nicole K.
Publicado: (2021)

α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization
por: Feller, Benjamin, et al.
Publicado: (2023)

Phytochemical and Pharmacological Role of Liquiritigenin and Isoliquiritigenin From Radix Glycyrrhizae in Human Health and Disease Models
por: Ramalingam, Mahesh, et al.
Publicado: (2018)

Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson’s Disease
por: Kim, Heejeong, et al.
Publicado: (2022)

Poly (ADP-ribose) in the pathogenesis of Parkinson's disease
por: Lee, Yunjong, et al.
Publicado: (2014)

Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils
por: Roux, Amandine, et al.
Publicado: (2020)

14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
por: Underwood, Rachel, et al.
Publicado: (2021)

VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2
por: Yun, Seung Pil, et al.
Publicado: (2017)

Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
por: Boi, Laura, et al.
Publicado: (2020)

Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson’s Disease
por: Ham, Sangwoo, et al.
Publicado: (2019)

Absence of Uptake and Prion-Like Spreading of Alpha-Synuclein and Tau After Intravitreal Injection of Preformed Fibrils
por: Veys, Lien, et al.
Publicado: (2021)

Microglial depletion does not impact alpha-synuclein aggregation or nigrostriatal degeneration in the rat preformed fibril model
por: Stoll, Anna C., et al.
Publicado: (2023)

Estrogen receptor activation contributes to RNF146 expression and neuroprotection in Parkinson's disease models
por: Kim, Hyojung, et al.
Publicado: (2017)

CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation
por: Kim, Hyojung, et al.
Publicado: (2017)

Intranasal administration of α-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis
por: Guo, Jian-Jun, et al.
Publicado: (2021)

Single Molecule Fingerprinting Reveals Different Amplification Properties of α-Synuclein Oligomers and Preformed Fibrils in Seeding Assay
por: Lau, Derrick, et al.
Publicado: (2022)

Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits
por: Negrini, Matilde, et al.
Publicado: (2022)

Polyphenolic Biflavonoids Inhibit Amyloid-Beta Fibrillation and Disaggregate Preformed Amyloid-Beta Fibrils
por: Choi, Erika Y., et al.
Publicado: (2020)

Observation of α-Synuclein Preformed Fibrils Interacting with SH-SY5Y Neuroblastoma Cell Membranes Using Scanning Ion Conductance Microscopy
por: Feng, Christina, et al.
Publicado: (2022)

A novel extended form of alpha-synuclein 3′UTR in the human brain
por: Je, Goun, et al.
Publicado: (2018)

Temperature-Dependent Structural Changes of Parkinson's Alpha-Synuclein Reveal the Role of Pre-Existing Oligomers in Alpha-Synuclein Fibrillization
por: Ariesandi, Winny, et al.
Publicado: (2013)

Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson’s Disease: A Nationwide Cohort Study
por: Jo, Youngkwon, et al.
Publicado: (2022)

Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve
por: Uemura, Norihito, et al.
Publicado: (2018)

Overexpression of Parkinson’s Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology
por: Xiong, Yulan, et al.
Publicado: (2017)

Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson’s disease
por: Yang, Yunseon, et al.
Publicado: (2022)

Identification and evaluation of midbrain specific longevity-related genes in exceptionally long-lived but healthy mice
por: Kim, Hyojung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_192009chdonp4ms40e081qp1to